Literature DB >> 10520996

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover.

K Holmbeck1, P Bianco, J Caterina, S Yamada, M Kromer, S A Kuznetsov, M Mankani, P G Robey, A R Poole, I Pidoux, J M Ward, H Birkedal-Hansen.   

Abstract

MT1-MMP is a membrane-bound matrix metalloproteinase (MT-MMP) capable of mediating pericellular proteolysis of extracellular matrix components. MT1-MMP is therefore thought to be an important molecular tool for cellular remodeling of the surrounding matrix. To establish the biological role of this membrane proteinase we generated MT1-MMP-deficient mice by gene targeting. MT1-MMP deficiency causes craniofacial dysmorphism, arthritis, osteopenia, dwarfism, and fibrosis of soft tissues due to ablation of a collagenolytic activity that is essential for modeling of skeletal and extraskeletal connective tissues. Our findings demonstrate the pivotal function of MT1-MMP in connective tissue metabolism, and illustrate that modeling of the soft connective tissue matrix by resident cells is essential for the development and maintenance of the hard tissues of the skeleton.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10520996     DOI: 10.1016/s0092-8674(00)80064-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  391 in total

1.  Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.

Authors:  L Guedez; A J McMarlin; D W Kingma; T A Bennett; M Stetler-Stevenson; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I.

Authors:  Z Zhou; S S Apte; R Soininen; R Cao; G Y Baaklini; R W Rauser; J Wang; Y Cao; K Tryggvason
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 3.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

4.  Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis.

Authors:  A Jiang; K Lehti; X Wang; S J Weiss; J Keski-Oja; D Pei
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

5.  Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.

Authors:  B Annabi; A Pilorget; N Bousquet-Gagnon; D Gingras; R Béliveau
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

Review 6.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

7.  How deeply cells feel: methods for thin gels.

Authors:  Amnon Buxboim; Karthikan Rajagopal; Andre' E X Brown; Dennis E Discher
Journal:  J Phys Condens Matter       Date:  2010-05-19       Impact factor: 2.333

8.  TGF-beta3-induced palatogenesis requires matrix metalloproteinases.

Authors:  L Blavier; A Lazaryev; J Groffen; N Heisterkamp; Y A DeClerck; V Kaartinen
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 9.  ECM roles in the function of metabolic tissues.

Authors:  Guorui Huang; Daniel S Greenspan
Journal:  Trends Endocrinol Metab       Date:  2011-11-08       Impact factor: 12.015

10.  Potential relation of aberrant proteolysis of human protein tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects.

Authors:  Vladislav S Golubkov; Alexander E Aleshin; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.